Literature DB >> 19876891

No effect of irinotecan in patients with resistant desmoplastic small round cell tumor.

Gianni Bisogno, Riccardo Riccardi, Angela Scagnellato, Giampaolo Arcamone, Lucia Miglionico, Modesto Carli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 19876891     DOI： 10.1002/pbc.22260

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


× No keyword cloud information.
  2 in total

1.  Antiangiogenic effects in patients with progressive desmoplastic small round cell tumor: data from the French national registry dedicated to the use of off-labeled targeted therapy in sarcoma (OUTC's).

Authors:  Sarah Bétrian; Christophe Bergeron; Jean-Yves Blay; Emmanuelle Bompas; Philippe A Cassier; Laure Chevallier; Jérome Fayette; Magali Girodet; Cécile Guillemet; Axel Le Cesne; Perrine Marec-Berard; Isabelle Ray-Coquard; Christine Chevreau
Journal:  Clin Sarcoma Res       Date:  2017-05-10

2.  Irinotecan and vincristine for the treatment of refractory desmoplastic small round cell tumor in a developing country: a case report.

Authors:  Natalia Brenneken Duarte Ambar; Maria Teresa de Seixas Alves; Henrique Manoel Lederman; Simone Abib; Alexandre Alberto Barros Duarte; Eliana Monteiro Caran
Journal:  J Med Case Rep       Date:  2019-03-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.